|
Volumn 115, Issue , 1989, Pages 36-42
|
Neoadjuvant chemotherapy in the conservative management of breast cancer: a study of 252 patients.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AVTMF PROTOCOL;
DOXORUBICIN;
FLUOROURACIL;
METHOTREXATE;
TAMOXIFEN;
THIOTEPA;
VINBLASTINE;
VTMF PROTOCOL;
ADULT;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
RANDOMIZATION;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
HUMANS;
METHOTREXATE;
MIDDLE AGED;
PROGNOSIS;
RANDOM ALLOCATION;
TAMOXIFEN;
THIOTEPA;
VINBLASTINE;
|
EID: 0024794171
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-83337-3_6 Document Type: Article |
Times cited : (9)
|
References (0)
|